Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Aurobindo Pharma
Pharmaceutical Preparation ManufacturingIndiaNSE: AUROPHARMA.NS
Last verified 9 months agoaurobindo.com
Aurobindo Pharma Limited, often referred to simply as Aurobindo, is a leading Indian multinational pharmaceutical manufacturing company. Headquartered in Hyderabad, India, it boasts a significant global footprint with operations spanning numerous countries worldwide.
Established in 1987, Aurobindo Pharma specialises in the production of high-quality pharmaceutical preparations. Their extensive portfolio encompasses active pharmaceutical ingredients (APIs), generics, and biosimilars, serving a broad range of therapeutic areas.
Renowned for its vertically integrated business model, Aurobindo excels in delivering affordable and accessible medicines. This strategic approach has cemented its position as a major player in the global pharmaceutical market, consistently contributing to healthcare innovation and accessibility.
46
DitchCarbon score
+4 vs industry average
Aurobindo Pharma’s score of 46 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Aurobindo Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Aurobindo Pharma's reported carbon emissions
In 2025, Aurobindo Pharma reported total carbon emissions of approximately 1.23 billion kg CO2e. This figure includes Scope 1 emissions of about 750.6 million kg CO2e, Scope 2 emissions of approximately 474.8 million kg CO2e, and Scope 3 emissions, which encompass various categories such as capital goods and business travel, amounting to a total of about 12.5 million kg CO2e.
The company has set ambitious climate commitments, aiming for a 12.5% reduction in its carbon footprint by 2025, in line with the Science Based Targets initiative (SBTi) for a well below 2°C scenario. This target applies to both Scope 1 and Scope 2 emissions, reflecting Aurobindo Pharma's commitment to sustainability and climate action.
Over the past few years, Aurobindo Pharma's emissions have shown fluctuations, with total emissions recorded at approximately 967.5 million kg CO2e in 2024 and about 941.5 million kg CO2e in 2023. The company has been actively working on reducing its carbon intensity, with reported reductions in energy intensity and overall carbon emissions in previous years.
Aurobindo Pharma's climate strategy is not only focused on compliance but also on proactive measures to mitigate environmental impact, demonstrating its commitment to sustainable practices within the pharmaceutical industry.
Assessing Aurobindo Pharma as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Aurobindo Pharma and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Aurobindo Pharma’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
8 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
2025 disclosureSee details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Aurobindo Pharma9 months ago
46
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more